Frostegård J - Search Results

1

Prediction and management of cardiovascular outcomes in systemic lupus erythematosus.

Frostegård J. Frostegård J. Expert Rev Clin Immunol. 2015 Feb;11(2):247-53. doi: 10.1586/1744666X.2015.993970. Epub 2014 Dec 17. Expert Rev Clin Immunol. 2015. PMID: 25517760 Review.

2

Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus.

Wu R, Svenungsson E, Gunnarsson I, Haegerstrand-Gillis C, Andersson B, Lundberg I, Elinder LS, Frostegård J. Wu R, et al. Among authors: frostegard j. Clin Exp Immunol. 1999 Mar;115(3):561-6. doi: 10.1046/j.1365-2249.1999.00830.x. Clin Exp Immunol. 1999. PMID: 10193434 Free PMC article.

3

Risk factors for cardiovascular disease in systemic lupus erythematosus.

Svenungsson E, Jensen-Urstad K, Heimbürger M, Silveira A, Hamsten A, de Faire U, Witztum JL, Frostegård J. Svenungsson E, et al. Among authors: frostegard j. Circulation. 2001 Oct 16;104(16):1887-93. doi: 10.1161/hc4101.097518. Circulation. 2001. PMID: 11602489

4

Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease.

Jensen-Urstad K, Svenungsson E, de Faire U, Silveira A, Witztum JL, Hamsten A, Frostegård J. Jensen-Urstad K, et al. Among authors: frostegard j. Lupus. 2002;11(11):744-52. doi: 10.1191/0961203302lu254oa. Lupus. 2002. PMID: 12475005

5

Autoimmunity, oxidized LDL and cardiovascular disease.

Frostegård J. Frostegård J. Autoimmun Rev. 2002 Aug;1(4):233-7. doi: 10.1016/s1568-9972(02)00059-9. Autoimmun Rev. 2002. PMID: 12849001 Review.

6

TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease.

Svenungsson E, Fei GZ, Jensen-Urstad K, de Faire U, Hamsten A, Frostegard J. Svenungsson E, et al. Among authors: frostegard j. Lupus. 2003;12(6):454-61. doi: 10.1191/0961203303lu412oa. Lupus. 2003. PMID: 12873047

7

Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.

Svenungsson E, Gunnarsson I, Fei GZ, Lundberg IE, Klareskog L, Frostegård J. Svenungsson E, et al. Among authors: frostegard j. Arthritis Rheum. 2003 Sep;48(9):2533-40. doi: 10.1002/art.11264. Arthritis Rheum. 2003. PMID: 13130473 Free article.

8

Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus.

Cederholm A, Svenungsson E, Stengel D, Fei GZ, Pockley AG, Ninio E, Frostegård J. Cederholm A, et al. Among authors: frostegard j. Arthritis Rheum. 2004 Sep;50(9):2869-76. doi: 10.1002/art.20432. Arthritis Rheum. 2004. PMID: 15457454 Free article.

9

The A-1087IL-10 allele is associated with cardiovascular disease in SLE.

Fei GZ, Svenungsson E, Frostegård J, Padyukov L. Fei GZ, et al. Among authors: frostegard j. Atherosclerosis. 2004 Dec;177(2):409-14. doi: 10.1016/j.atherosclerosis.2004.07.026. Atherosclerosis. 2004. PMID: 15530917

10

Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus.

Cederholm A, Svenungsson E, Jensen-Urstad K, Trollmo C, Ulfgren AK, Swedenborg J, Fei GZ, Frostegård J. Cederholm A, et al. Among authors: frostegard j. Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):198-203. doi: 10.1161/01.ATV.0000150415.18759.36. Epub 2004 Nov 11. Arterioscler Thromb Vasc Biol. 2005. PMID: 15539620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page